Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.

The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.

Precision immunodiagnostic firm Navidea Biopharmaceuticals named Michael Rosol, Ph.D., to be its new chief medical officer, effective Dec. 17.

Medtronic will pay nearly $51 million to settle claims against two of its acquisitions related to unapproved device promotions and alleged kickbacks.

Sanofi and Sema4 launched a five-year study of nearly 1,200 asthma patients, incorporating digital tools to better understand the disease.

Australian researchers discovered a unique DNA structure that could be used to help diagnose cancer in under 10 minutes with the naked eye.

Siemens Healthineers held a ribbon-cutting ceremony for its $300 million expansion of its manufacturing and R&D facility in Walpole, Massachusetts.

The FDA granted Bayer and Merck breakthrough device status for AI-based software that spots a rare form of pulmonary hypertension in CT scans.